Literature DB >> 22699619

Autistic-like behaviours and hyperactivity in mice lacking ProSAP1/Shank2.

Michael J Schmeisser1, Elodie Ey, Stephanie Wegener, Juergen Bockmann, A Vanessa Stempel, Angelika Kuebler, Anna-Lena Janssen, Patrick T Udvardi, Ehab Shiban, Christina Spilker, Detlef Balschun, Boris V Skryabin, Susanne tom Dieck, Karl-Heinz Smalla, Dirk Montag, Claire S Leblond, Philippe Faure, Nicolas Torquet, Anne-Marie Le Sourd, Roberto Toro, Andreas M Grabrucker, Sarah A Shoichet, Dietmar Schmitz, Michael R Kreutz, Thomas Bourgeron, Eckart D Gundelfinger, Tobias M Boeckers.   

Abstract

Autism spectrum disorders comprise a range of neurodevelopmental disorders characterized by deficits in social interaction and communication, and by repetitive behaviour. Mutations in synaptic proteins such as neuroligins, neurexins, GKAPs/SAPAPs and ProSAPs/Shanks were identified in patients with autism spectrum disorder, but the causative mechanisms remain largely unknown. ProSAPs/Shanks build large homo- and heteromeric protein complexes at excitatory synapses and organize the complex protein machinery of the postsynaptic density in a laminar fashion. Here we demonstrate that genetic deletion of ProSAP1/Shank2 results in an early, brain-region-specific upregulation of ionotropic glutamate receptors at the synapse and increased levels of ProSAP2/Shank3. Moreover, ProSAP1/Shank2(-/-) mutants exhibit fewer dendritic spines and show reduced basal synaptic transmission, a reduced frequency of miniature excitatory postsynaptic currents and enhanced N-methyl-d-aspartate receptor-mediated excitatory currents at the physiological level. Mutants are extremely hyperactive and display profound autistic-like behavioural alterations including repetitive grooming as well as abnormalities in vocal and social behaviours. By comparing the data on ProSAP1/Shank2(-/-) mutants with ProSAP2/Shank3αβ(-/-) mice, we show that different abnormalities in synaptic glutamate receptor expression can cause alterations in social interactions and communication. Accordingly, we propose that appropriate therapies for autism spectrum disorders are to be carefully matched to the underlying synaptopathic phenotype.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22699619     DOI: 10.1038/nature11015

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  36 in total

1.  Presynaptic kainate receptors impart an associative property to hippocampal mossy fiber long-term potentiation.

Authors:  Dietmar Schmitz; Jack Mellor; Joerg Breustedt; Roger A Nicoll
Journal:  Nat Neurosci       Date:  2003-08-31       Impact factor: 24.884

2.  An autism-associated point mutation in the neuroligin cytoplasmic tail selectively impairs AMPA receptor-mediated synaptic transmission in hippocampus.

Authors:  Mark R Etherton; Katsuhiko Tabuchi; Manu Sharma; Jaewon Ko; Thomas C Südhof
Journal:  EMBO J       Date:  2011-06-03       Impact factor: 11.598

3.  Unusual repertoire of vocalizations in adult BTBR T+tf/J mice during three types of social encounters.

Authors:  M L Scattoni; L Ricceri; J N Crawley
Journal:  Genes Brain Behav       Date:  2011-02       Impact factor: 3.449

Review 4.  Postsynaptic ProSAP/Shank scaffolds in the cross-hair of synaptopathies.

Authors:  Andreas M Grabrucker; Michael J Schmeisser; Michael Schoen; Tobias M Boeckers
Journal:  Trends Cell Biol       Date:  2011-08-15       Impact factor: 20.808

5.  Automated apparatus for quantitation of social approach behaviors in mice.

Authors:  J J Nadler; S S Moy; G Dold; D Trang; N Simmons; A Perez; N B Young; R P Barbaro; J Piven; T R Magnuson; J N Crawley
Journal:  Genes Brain Behav       Date:  2004-10       Impact factor: 3.449

6.  Disruption of neurexin 1 associated with autism spectrum disorder.

Authors:  Hyung-Goo Kim; Shotaro Kishikawa; Anne W Higgins; Ihn-Sik Seong; Diana J Donovan; Yiping Shen; Eric Lally; Lauren A Weiss; Juliane Najm; Kerstin Kutsche; Maria Descartes; Lynn Holt; Stephen Braddock; Robin Troxell; Lee Kaplan; Fred Volkmar; Ami Klin; Katherine Tsatsanis; David J Harris; Ilse Noens; David L Pauls; Mark J Daly; Marcy E MacDonald; Cynthia C Morton; Bradley J Quade; James F Gusella
Journal:  Am J Hum Genet       Date:  2008-01       Impact factor: 11.025

7.  Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes.

Authors:  Hsiao-Tuan Chao; Hongmei Chen; Rodney C Samaco; Mingshan Xue; Maria Chahrour; Jong Yoo; Jeffrey L Neul; Shiaoching Gong; Hui-Chen Lu; Nathaniel Heintz; Marc Ekker; John L R Rubenstein; Jeffrey L Noebels; Christian Rosenmund; Huda Y Zoghbi
Journal:  Nature       Date:  2010-11-11       Impact factor: 49.962

8.  Shank3 mutant mice display autistic-like behaviours and striatal dysfunction.

Authors:  João Peça; Cátia Feliciano; Jonathan T Ting; Wenting Wang; Michael F Wells; Talaignair N Venkatraman; Christopher D Lascola; Zhanyan Fu; Guoping Feng
Journal:  Nature       Date:  2011-03-20       Impact factor: 49.962

9.  Haploinsufficiency of the autism-associated Shank3 gene leads to deficits in synaptic function, social interaction, and social communication.

Authors:  Ozlem Bozdagi; Takeshi Sakurai; Danae Papapetrou; Xiaobin Wang; Dara L Dickstein; Nagahide Takahashi; Yuji Kajiwara; Mu Yang; Adam M Katz; Maria Luisa Scattoni; Mark J Harris; Roheeni Saxena; Jill L Silverman; Jacqueline N Crawley; Qiang Zhou; Patrick R Hof; Joseph D Buxbaum
Journal:  Mol Autism       Date:  2010-12-17       Impact factor: 7.509

10.  Genetic and functional analyses of SHANK2 mutations suggest a multiple hit model of autism spectrum disorders.

Authors:  Claire S Leblond; Jutta Heinrich; Richard Delorme; Christian Proepper; Catalina Betancur; Guillaume Huguet; Marina Konyukh; Pauline Chaste; Elodie Ey; Maria Rastam; Henrik Anckarsäter; Gudrun Nygren; I Carina Gillberg; Jonas Melke; Roberto Toro; Beatrice Regnault; Fabien Fauchereau; Oriane Mercati; Nathalie Lemière; David Skuse; Martin Poot; Richard Holt; Anthony P Monaco; Irma Järvelä; Katri Kantojärvi; Raija Vanhala; Sarah Curran; David A Collier; Patrick Bolton; Andreas Chiocchetti; Sabine M Klauck; Fritz Poustka; Christine M Freitag; Regina Waltes; Marnie Kopp; Eftichia Duketis; Elena Bacchelli; Fiorella Minopoli; Liliana Ruta; Agatino Battaglia; Luigi Mazzone; Elena Maestrini; Ana F Sequeira; Barbara Oliveira; Astrid Vicente; Guiomar Oliveira; Dalila Pinto; Stephen W Scherer; Diana Zelenika; Marc Delepine; Mark Lathrop; Dominique Bonneau; Vincent Guinchat; Françoise Devillard; Brigitte Assouline; Marie-Christine Mouren; Marion Leboyer; Christopher Gillberg; Tobias M Boeckers; Thomas Bourgeron
Journal:  PLoS Genet       Date:  2012-02-09       Impact factor: 5.917

View more
  262 in total

Review 1.  From the genetic architecture to synaptic plasticity in autism spectrum disorder.

Authors:  Thomas Bourgeron
Journal:  Nat Rev Neurosci       Date:  2015-09       Impact factor: 34.870

2.  SHANK Mutations May Disorder Brain Development.

Authors:  Martin Poot
Journal:  Mol Syndromol       Date:  2015-02

3.  Mice with Shank3 Mutations Associated with ASD and Schizophrenia Display Both Shared and Distinct Defects.

Authors:  Yang Zhou; Tobias Kaiser; Patrícia Monteiro; Xiangyu Zhang; Marie S Van der Goes; Dongqing Wang; Boaz Barak; Menglong Zeng; Chenchen Li; Congyi Lu; Michael Wells; Aldo Amaya; Shannon Nguyen; Michael Lewis; Neville Sanjana; Yongdi Zhou; Mingjie Zhang; Feng Zhang; Zhanyan Fu; Guoping Feng
Journal:  Neuron       Date:  2015-12-10       Impact factor: 17.173

4.  Methamphetamine augment HIV-1 Tat mediated memory deficits by altering the expression of synaptic proteins and neurotrophic factors.

Authors:  Anantha Ram Nookala; Daniel C Schwartz; Nitish S Chaudhari; Alexy Glazyrin; Edward B Stephens; Nancy E J Berman; Anil Kumar
Journal:  Brain Behav Immun       Date:  2018-05-02       Impact factor: 7.217

Review 5.  Activity-dependent neuronal signalling and autism spectrum disorder.

Authors:  Daniel H Ebert; Michael E Greenberg
Journal:  Nature       Date:  2013-01-17       Impact factor: 49.962

Review 6.  Advancing the discovery of medications for autism spectrum disorder using new technologies to reveal social brain circuitry in rodents.

Authors:  Martien J Kas; Meera E Modi; Michael D Saxe; Daniel G Smith
Journal:  Psychopharmacology (Berl)       Date:  2014-02-13       Impact factor: 4.530

7.  The Neurobiological Basis for Social Affiliation in Autism Spectrum Disorder and Schizophrenia.

Authors:  Amanda Crider; Anilkumar Pillai
Journal:  Curr Behav Neurosci Rep       Date:  2016-04-16

Review 8.  Modeling autism by SHANK gene mutations in mice.

Authors:  Yong-Hui Jiang; Michael D Ehlers
Journal:  Neuron       Date:  2013-04-10       Impact factor: 17.173

9.  Engineered deafness reveals that mouse courtship vocalizations do not require auditory experience.

Authors:  Elena J Mahrt; David J Perkel; Ling Tong; Edwin W Rubel; Christine V Portfors
Journal:  J Neurosci       Date:  2013-03-27       Impact factor: 6.167

Review 10.  Therapeutic approaches for shankopathies.

Authors:  Xiaoming Wang; Alexandra L Bey; Leeyup Chung; Andrew D Krystal; Yong-Hui Jiang
Journal:  Dev Neurobiol       Date:  2013-10-11       Impact factor: 3.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.